• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa.

作者信息

Girisch Monika, Rauch Ralf, Carbon Roman, Habash Thomas, Hofbeck Michael

机构信息

Department of Cardiology and Intensive Care Medicine, University Children's Hospital Tübingen, Hoppe-Seyler-Strasse 3, 72076 Tübingen, Germany.

出版信息

Eur J Pediatr. 2004 Feb;163(2):118-9. doi: 10.1007/s00431-003-1369-6. Epub 2004 Jan 10.

DOI:10.1007/s00431-003-1369-6
PMID:14716558
Abstract
摘要

相似文献

1
Refractory bleeding following major surgery of a giant sacrococcygeal teratoma in a premature infant: successful use of recombinant factor VIIa.早产儿巨大骶尾部畸胎瘤大手术后难治性出血：重组凝血因子VIIa的成功应用
Eur J Pediatr. 2004 Feb;163(2):118-9. doi: 10.1007/s00431-003-1369-6. Epub 2004 Jan 10.
2
Use of recombinant factor VIIa for bleeding in children with Glanzmann thrombasthenia.重组凝血因子VIIa用于治疗Glanzmann血小板无力症患儿出血
Pediatr Hematol Oncol. 2003 Sep;20(6):435-8.
3
Successful graft patency after factor VIIa use for bleeding in coronary artery surgery: an unusual complication of a coronary artery bypass surgery.冠状动脉手术中使用凝血因子VIIa治疗出血后移植物通畅成功：冠状动脉搭桥手术的一种罕见并发症
J Card Surg. 2007 Sep-Oct;22(5):424-7. doi: 10.1111/j.1540-8191.2007.00440.x.
4
Recombinant factor VIIa use in cardiac surgery--expanding the arsenal therapy for intractable bleeding?
J Cardiovasc Surg (Torino). 2004 Dec;45(6):569-71.
5
The use of recombinant factor VIIa in a patient with Noonan syndrome and life-threatening bleeding.重组凝血因子VIIa在一名患有努南综合征且有危及生命出血的患者中的应用。
Pediatr Crit Care Med. 2005 May;6(3):352-4. doi: 10.1097/01.PCC.0000160656.71424.D1.
6
Off-label use of recombinant factor VIIA concentrates after cardiac surgery.心脏手术后重组凝血因子VIIA浓缩剂的非标签使用。
Ann Thorac Surg. 2005 Jul;80(1):3-5. doi: 10.1016/j.athoracsur.2005.04.007.
7
Recombinant factor VIIa for treatment of massive liver fracture in a premature infant.重组凝血因子VIIa用于治疗早产儿严重肝破裂
J Pediatr Surg. 2006 Oct;41(10):1764-7. doi: 10.1016/j.jpedsurg.2006.05.054.
8
Use of recombinant factor VIIa in a preterm infant with coagulopathy and subdural hematoma.重组凝血因子VIIa在一名患有凝血病和硬膜下血肿的早产儿中的应用。
J Matern Fetal Neonatal Med. 2007 Aug;20(8):627-9. doi: 10.1080/14767050701411935.
9
Pharmacologic therapy for postoperative bleeding in children after cardiac surgery: when will the bleeding stop?小儿心脏手术后出血的药物治疗：出血何时会停止？
Pediatr Crit Care Med. 2004 May;5(3):297-8. doi: 10.1097/01.pcc.0000124016.68179.8c.
10
Devascularization and staged resection of giant sacrococcygeal teratoma in the premature infant.早产儿巨大骶尾部畸胎瘤的去血管化及分期切除术
J Pediatr Surg. 1995 Feb;30(2):309-11. doi: 10.1016/0022-3468(95)90579-0.

引用本文的文献

1
Cardiac arrest during excision of a huge sacrococcygeal teratoma - A report of two cases -.巨大骶尾部畸胎瘤切除术中发生心跳骤停——两例报告。
Korean J Anesthesiol. 2012 Jul;63(1):80-4. doi: 10.4097/kjae.2012.63.1.80. Epub 2012 Jul 24.
2
Complications with massive sacrococcygeal tumor resection on a premature neonate.巨大骶尾部肿瘤切除术后早产儿出现并发症。
J Anesth. 2010 Dec;24(6):951-4. doi: 10.1007/s00540-010-1027-x. Epub 2010 Nov 6.
3
Recombinant activated factor VIIa treatment for refractory hemorrhage in infants.重组活化凝血因子 VIIa 治疗婴儿难治性出血。

本文引用的文献

1
Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial.重组活化凝血因子VII对耻骨后前列腺切除术患者围手术期失血的影响：一项双盲安慰剂对照随机试验。
Lancet. 2003 Jan 18;361(9353):201-5. doi: 10.1016/S0140-6736(03)12268-4.
2
Life-threatening hemorrhage in neonates: management with recombinant activated factor VII.新生儿危及生命的出血：重组活化因子VII的治疗
Intensive Care Med. 2002 Nov;28(11):1635-7. doi: 10.1007/s00134-002-1489-x. Epub 2002 Sep 11.
3
Updates in the management of severe coagulopathy in trauma patients.
J Perinatol. 2011 Mar;31(3):188-92. doi: 10.1038/jp.2010.85. Epub 2010 Jul 29.
4
Recombinant activated factor VIIa for the treatment of bleeding in major abdominal surgery including vascular and urological surgery: a review and meta-analysis of published data.重组活化凝血因子VIIa用于治疗包括血管和泌尿外科手术在内的重大腹部手术中的出血：已发表数据的综述与荟萃分析
Crit Care. 2008;12(1):R14. doi: 10.1186/cc6788. Epub 2008 Feb 15.
创伤患者严重凝血病管理的进展
Intensive Care Med. 2002 Oct;28 Suppl 2:S241-7. doi: 10.1007/s00134-002-1471-7.
4
The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing exploratory laparotomy.使用重组活化因子VII控制一名接受剖腹探查术的早产儿的出血。
Pediatrics. 2002 Jul;110(1 Pt 1):169-71. doi: 10.1542/peds.110.1.169.
5
Successful use of recombinant activated factor VII for trauma-associated hemorrhage in a patient without preexisting coagulopathy.重组活化凝血因子 VII 在一名无既往凝血功能障碍患者创伤相关出血治疗中的成功应用。
J Trauma. 2002 Feb;52(2):400-5. doi: 10.1097/00005373-200202000-00034.
6
Successful use of recombinant FVIIa (Novoseven) in the management of intractable post-surgical intra-abdominal haemorrhage.重组凝血因子VIIa（诺其）成功用于治疗难治性术后腹腔内出血。
Br J Haematol. 1999 Dec;107(3):677-8. doi: 10.1046/j.1365-2141.1999.01798.x.
7
Sacrococcygeal teratoma: American Academy of Pediatrics Surgical Section Survey-1973.骶尾部畸胎瘤：美国儿科学会外科分会调查 - 1973年
J Pediatr Surg. 1974 Jun;9(3):389-98. doi: 10.1016/s0022-3468(74)80297-6.
8
Death due to high-output cardiac failure in fetal sacrococcygeal teratoma.胎儿骶尾部畸胎瘤所致高输出量心力衰竭死亡
J Pediatr Surg. 1990 Dec;25(12):1287-91. doi: 10.1016/0022-3468(90)90535-h.
9
Coagulopathy associated with large sacrococcygeal teratomas.
J Pediatr Surg. 1992 Oct;27(10):1308-10. doi: 10.1016/0022-3468(92)90282-c.
10
Benign and malignant teratomas in children: analysis of 85 patients.儿童良性与恶性畸胎瘤：85例患者分析
Surgery. 1976 Sep;80(3):297-305.